P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease is a research paper published in EMBO Molecular Medicine (2021). On theSindex it has a DataRank of 0.614. It has been cited 59 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.614
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Alzheimer's Drug Discovery Foundation
Grant: RDAPB‐201809‐2016615
Alzheimer's Drug Discovery Foundation
Grant: 201809‐2016862
Academy of Finland
Grant: 341059
Interplay of synaptic changes, neuroinflammation and beta-amyloid in cognitively normal subjects with varying risk of late-onset Alzheimers disease (ASIC-E4)
H2020 European Research Council
Grant: 681712
Pathways to Alzheimer's disease
Instituto de Salud Carlos III
Grant: PI19/00155
Medical Research Council
Grant: UKDRI-1003
European Research Council
Grant: 948677
Identification of age-related Human Blood factors as a therapeutic target for Alzheimer's disease
NIA NIH HHS
Grant: R01 AG068398
European Commission
Grant: 860197
Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis
European Commission
Grant: 825664
ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
National Institutes of Health
Grant: 1R01AG068398-01
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
National Institutes of Health
Grant: 5R01AG068398-02
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
FWCI
5.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals